De novo erythropoietin receptor (EPO-R) expression in human neoplastic glial cells decreases with grade of malignancy but is favourably associated with patient survival

M. Mittelbronn*, D. Capper, B. Bunz, K. Dietz, B. Goeppert, R. Ajaaj, G. Tabatabai, F. Stubenvoll, H. Schlaszus, A. S. Merseburger, R. Becker, D. Freudenstein, W. Wick, M. Weller, R. Meyermann, P. Simon

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

18 Citations (Scopus)

Fingerprint

Dive into the research topics of 'De novo erythropoietin receptor (EPO-R) expression in human neoplastic glial cells decreases with grade of malignancy but is favourably associated with patient survival'. Together they form a unique fingerprint.

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

Neuroscience

Immunology and Microbiology